Aignostics Launches HETA Clinical, a New Family of AI Products that Speed Up Pathology Workflows and Reduce Failed Molecular Tests
BERLIN and NEW YORK, Oct. 16, 2026 /PRNewswire/ -- Today, Aignostics announced the launch of HETA Clinical, a new family of pan-cancer AI products spanning the pathology workflow from intake and evaluation to molecular testing. The first four HETA Clinical products measure slide quality,...
Short extract only — this publisher licenses its text. Read the full release at the source.
Cancel anytime · CA$99/month


